共 17 条
- [1] miR-590-5p和miR-590-3p参与肝细胞肝癌发展的机制[J]. 杨红飞,郑文宏,赵文淘,关春燕,安靓.南方医科大学学报. 2013(06)
- [2] MicroRNAs role as potential biomarkers and key regulators in melanoma [J]. GENES CHROMOSOMES & CANCER, 2017, 56 (01): : 3 - 10
- [4] miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential[J] . Michal Wozniak,Aleksandra Mielczarek,Malgorzata Czyz.Current Medicinal Chemistry . 2016 (28)
- [5] Cancer statistics in China, 2015[J] . Wanqing Chen,Rongshou Zheng,Peter D. Baade,Siwei Zhang,Hongmei Zeng,Freddie Bray,Ahmedin Jemal,Xue Qin Yu,Jie He.CA: A Cancer Journal for Clinicians . 2016 (2)
- [6] Cancer statistics, 2016[J] . Rebecca L. Siegel,Kimberly D. Miller,Ahmedin Jemal.CA: A Cancer Journal for Clinicians . 2016 (1)
- [7] The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors [J]. MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (01):
- [8] YAP and TAZ: a nexus for Hippo signaling and beyond[J] . Carsten Gram Hansen,Toshiro Moroishi,Kun-Liang Guan.Trends in Cell Biology . 2015 (9)
- [9] Genetic variants in Hippo pathway genes YAP 1, TEAD 1 and TEAD 4 are associated with melanoma‐specific survival[J] . Hua Yuan,Hongliang Liu,Zhensheng Liu,Dakai Zhu,Christopher I. Amos,Shenying Fang,Jeffrey E. Lee,Qingyi Wei.Int. J. Cancer . 2015 (3)
- [10] MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges[J] . Huiyin Lan,Haiqi Lu,Xian Wang,Hongchuan Jin,Francesco Nicassio.BioMed Research International . 2015